137 related articles for article (PubMed ID: 20150587)
1. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.
Wang L; Bao Y; Yang Y; Wu Y; Chen X; Si S; Hong B
J Biomol Screen; 2010 Mar; 15(3):239-50. PubMed ID: 20150587
[TBL] [Abstract][Full Text] [Related]
2. Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model.
Xu Y; Wang J; Bao Y; Jiang W; Zuo L; Song D; Hong B; Si S
Anal Biochem; 2010 May; 400(2):207-12. PubMed ID: 20152792
[TBL] [Abstract][Full Text] [Related]
3. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion.
Stewart BW; Nagarajan S
Mol Immunol; 2006 Feb; 43(3):255-67. PubMed ID: 16199262
[TBL] [Abstract][Full Text] [Related]
4. The expression of recombinant human LOX-1 and identifying its mimic ligands by fluorescence polarization-based high throughput screening.
Zhang T; Huang Z; Dai Y; Chen X; Zhu P; Du G
J Biotechnol; 2006 Oct; 125(4):492-502. PubMed ID: 16735073
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists.
Wang YX; Wang L; Xu YN; Li YH; Jiang JD; Si SY; Li YB; Ren G; Shan YQ; Hong B; Song DQ
Eur J Med Chem; 2011 Apr; 46(4):1066-73. PubMed ID: 21295889
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.
Yang Y; Zhang Z; Jiang W; Gao L; Zhao G; Zheng Z; Wang M; Si S; Hong B
J Biomol Screen; 2007 Mar; 12(2):211-9. PubMed ID: 17259591
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and structure-activity relationship of 13-hexylberberine analogues as CD36 antagonists].
Li YH; Wang L; Hong B; Xu YN; Si SY; Jiang JD; Song DQ
Yao Xue Xue Bao; 2010 Sep; 45(9):1128-33. PubMed ID: 21351569
[TBL] [Abstract][Full Text] [Related]
8. The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.
Malaud E; Hourton D; Giroux LM; Ninio E; Buckland R; McGregor JL
Biochem J; 2002 Jun; 364(Pt 2):507-15. PubMed ID: 12023894
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients.
Chmielewski M; Bragfors-Helin AC; Stenvinkel P; Lindholm B; Anderstam B
Clin Chim Acta; 2010 Dec; 411(23-24):2079-82. PubMed ID: 20837002
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis.
Schneiderhan W; Schmid-Kotsas A; Zhao J; Grünert A; Nüssler A; Weidenbach H; Menke A; Schmid RM; Adler G; Bachem MG
Hepatology; 2001 Oct; 34(4 Pt 1):729-37. PubMed ID: 11584369
[TBL] [Abstract][Full Text] [Related]
11. Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion.
Nagarajan S
Immunol Lett; 2007 Jan; 108(1):52-61. PubMed ID: 17081622
[TBL] [Abstract][Full Text] [Related]
12. High-throughput fluorescence polarization method for identifying ligands of LOX-1.
Zhang TT; Huang ZT; Dai Y; Chen XP; Zhu P; Du GH
Acta Pharmacol Sin; 2006 Apr; 27(4):447-52. PubMed ID: 16539845
[TBL] [Abstract][Full Text] [Related]
13. Dietary compound quercitrin dampens VEGF induction and PPARgamma activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36.
Choi JS; Bae JY; Kim DS; Li J; Kim JL; Lee YJ; Kang YH
J Agric Food Chem; 2010 Jan; 58(2):1333-41. PubMed ID: 19928818
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum-infected erythrocytes and oxidized low-density lipoprotein bind to separate domains of CD36.
Crandall I; Guy RA; Maguire GF; Connelly PW; Kain KC
J Infect Dis; 1999 Aug; 180(2):473-9. PubMed ID: 10395864
[TBL] [Abstract][Full Text] [Related]
15. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
16. Expression of caveolin-1 in hepatic cells increases oxidized LDL uptake and preserves the expression of lipoprotein receptors.
Truong TQ; Brodeur MR; Falstrault L; Rhainds D; Brissette L
J Cell Biochem; 2009 Nov; 108(4):906-15. PubMed ID: 19718657
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death.
Yoon IS; Au Q; Barber JR; Ng SC; Zhang B
Anal Biochem; 2010 Dec; 407(2):205-10. PubMed ID: 20705047
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
19. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
20. A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.
Gotoh Y; Nagata H; Kase H; Shimonishi M; Ido M
Anal Biochem; 2010 Oct; 405(1):19-27. PubMed ID: 20522330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
